Menu

• Ask a Health Expert about HYPERCALCAEMIA OF MALIGNANCY
• Post Your Side Effect related to HYPERCALCAEMIA OF MALIGNANCY
• HYPERCALCAEMIA OF MALIGNANCY and FDA Warnings
• HYPERCALCAEMIA OF MALIGNANCY in Patients Wiki
• Report HYPERCALCAEMIA OF MALIGNANCY in Drug Side Effect Survey

HYPERCALCAEMIA OF MALIGNANCY side effect

What is HYPERCALCAEMIA OF MALIGNANCY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Calcitriol Side Effects Report #5728854-7
Consumer or non-health professional from UNITED STATES reported CALCITRIOL problem on Apr 28, 2008. Female patient, 64 years of age, was diagnosed with osteoporosis and was treated with CALCITRIOL. After drug was administered, patient experienced the following problems/side effects: hypercalcaemia of malignancy, . CALCITRIOL dosage: unknown. During the same period patient was treated with RISEDRONATE, CALCIUM, ERGOCALCIFEROL. Patient recovered.

Pamidronate Side Effects Report #5578536-X
PAMIDRONATE ACID problem was reported by a Health Professional from UNITED KINGDOM on Dec 18, 2007. Male patient was diagnosed with hypercalcaemia of malignancy and was treated with PAMIDRONATE ACID. After drug was administered, patient experienced the following problems/side effects: condition aggravated, hypercalcaemia of malignancy, malignant neoplasm progression, metastases to central nervous system, metastases to lung, metastatic renal cell carcinoma, no therapeutic response, . PAMIDRONATE ACID dosage: 120 MG FREQ IV. During the same period patient was treated with ZOMETA, CALCITONIN SALMON, CALCITONIN SALMON, IBANDRONIC ACID, CLARITHROMYCIN, DEXAMETHASONE, GABAPENTIN, NYSTATIN. Patient died on 08/20/2007.

Femara Side Effects Report #5405142-X
Pharmacist from CANADA reported FEMARA problem on Aug 01, 2007. Female patient, 86 years of age, was diagnosed with breast cancer metastatic, metastases to bone and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: asthenia, confusional state, hypercalcaemia of malignancy, nausea, . FEMARA dosage: 2.5 MG, QD. During the same period patient was treated with PAMIDRONATE DI, MICARDIS, ZANTAC, VITAMIN B, XALATAN. Patient was hospitalized. Patient died on 06/01/2007.

Revlimid Side Effects Report #5762096-4
REVLIMID problem was reported by a Consumer or non-health professional from FRANCE on May 26, 2008. Female patient, 74 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiopulmonary failure, diaphragmatic disorder, hypercalcaemia of malignancy, neuropathy peripheral, neutropenia, pulmonary oedema, thrombocytopenia, wound, . REVLIMID dosage: unknown. During the same period patient was treated with VELCADE. Patient was hospitalized and became disabled. Patient recovered.